In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment.
Authors: Authors: Kowall NW, McKee AC, Yankner BA, Beal MF.
Neurobiol Aging
View full abstract on Pubmed
Neurobiol Aging
View full abstract on Pubmed
Methodological variables in the assessment of beta amyloid neurotoxicity.
Commentary and perspective on studies of beta amyloid neurotoxicity.
Seminars in medicine of the Beth Israel Hospital, Boston. beta-Amyloid and the pathogenesis of Alzheimer's disease.
An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.
Authors: Authors: Kowall NW, Beal MF, Busciglio J, Duffy LK, Yankner BA.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
Proc Natl Acad Sci U S A
View full abstract on Pubmed
An antibody to beta amyloid and the amyloid precursor protein inhibits cell-substratum adhesion in many mammalian cell types.
Nerve growth factor potentiates the neurotoxicity of beta amyloid.
Authors: Authors: Yankner BA, Caceres A, Duffy LK.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
Proc Natl Acad Sci U S A
View full abstract on Pubmed
Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.
Transfection of PC12 cells with the human GAP-43 gene: effects on neurite outgrowth and regeneration.
Authors: Authors: Yankner BA, Benowitz LI, Villa-Komaroff L, Neve RL.
Brain Res Mol Brain Res
View full abstract on Pubmed
Brain Res Mol Brain Res
View full abstract on Pubmed
Genetics and biology of the Alzheimer amyloid precursor.
Authors: Authors: Neve RL, Dawes LR, Yankner BA, Benowitz LI, Rodriguez W, Higgins GA.
Prog Brain Res
View full abstract on Pubmed
Prog Brain Res
View full abstract on Pubmed